0001140361-20-024544.txt : 20201104 0001140361-20-024544.hdr.sgml : 20201104 20201104161810 ACCESSION NUMBER: 0001140361-20-024544 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20201104 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20201104 DATE AS OF CHANGE: 20201104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NU SKIN ENTERPRISES, INC. CENTRAL INDEX KEY: 0001021561 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] IRS NUMBER: 870565309 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12421 FILM NUMBER: 201286941 BUSINESS ADDRESS: STREET 1: 75 WEST CENTER ST STREET 2: ATTN: GREGORY BELLISTON CITY: PROVO STATE: UT ZIP: 84601 BUSINESS PHONE: 801-345-1000 MAIL ADDRESS: STREET 1: 75 WEST CENTER ST STREET 2: ATTN: GREGORY BELLISTON CITY: PROVO STATE: UT ZIP: 84601 FORMER COMPANY: FORMER CONFORMED NAME: NU SKIN ENTERPRISES INC DATE OF NAME CHANGE: 19980909 FORMER COMPANY: FORMER CONFORMED NAME: NU SKIN ASIA PACIFIC INC DATE OF NAME CHANGE: 19960919 8-K 1 brhc10016590_8k.htm 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

November 4, 2020
Date of Report (Date of earliest event reported)
 
NU SKIN ENTERPRISES, INC.
(Exact name of registrant as specified in its charter)

Delaware
  
001-12421
  
87-0565309
(State or other jurisdiction of incorporation)
  
(Commission File Number)
 
(IRS Employer Identification Number)

75 West Center Street
Provo, Utah 84601
(Address of principal executive offices and zip code)
 
(801) 345-1000
(Registrant's telephone number, including area code)
 
N/A
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Class A Common Stock, $.001 par value
NUS
New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02
Results of Operations and Financial Condition.

On November 4, 2020, Nu Skin Enterprises, Inc. (the “Company”) issued a press release announcing its financial results for the three- and nine-month periods ended September 30, 2020, and certain other information. A copy of the press release is attached as Exhibit 99.1 to this report.

The information furnished pursuant to this Item 2.02 and the exhibit hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing.

The press release furnished herewith in Exhibit 99.1 contains non-GAAP financial measures. Management believes non-GAAP financial measures assist management and investors in evaluating and comparing period-to-period results and projections in a more meaningful and consistent manner.

Item 9.01
Financial Statements and Exhibits.

(d) Exhibits.

Nu Skin Enterprises’ press release dated November 4, 2020, regarding financial results for the three- and nine-month periods ended September 30, 2020.
   
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
NU SKIN ENTERPRISES, INC.
  
 
(Registrant)
  
     
 
/s/ Mark H. Lawrence
  
 
Mark H. Lawrence
  
 
Chief Financial Officer
  
     
Date:  November 4, 2020
    

 
EX-99.1 2 brhc10016590_ex99-1.htm PRESS RELEASE DATED NOVEMBER 4, 2020
Exhibit 99.1


FOR IMMEDIATE RELEASE

NU SKIN ENTERPRISES REPORTS THIRD-QUARTER 2020 RESULTS
AND RAISES ANNUAL GUIDANCE

PROVO, Utah — Nov. 4, 2020 — Nu Skin Enterprises, Inc. (NYSE: NUS) today announced third-quarter results of 19 percent revenue growth and 37 percent earnings per share growth and raised its guidance for 2020.

Executive Summary
Q3 2020 vs. Prior-Year Quarter

Revenue:
    
$703.3 million; +19%
•          Less than (1%) fx impact
Earnings Per Share (EPS):
    
$1.08; +37%
Sales Leaders:
    
68,516; +12%
Customers:
    
1,539,511; +28%

“We continued to build momentum with accelerated results in the third quarter, as we generated revenue and earnings per share well above expectations,” said Ritch Wood, chief executive officer. “As we executed on our long-term strategy, we drove double-digit growth in both customers and sales leaders with revenue improvements in all but one reporting segment. We delivered strong double-digit growth in the Americas, Pacific and EMEA regions, with modest growth throughout most of Asia. Mainland China continues to stabilize with sequentially improving revenue, customers and sales leaders, and we remain on track for a return to year-over-year growth in China in the fourth quarter. Our manufacturing division contributed to our results with impressive 34 percent growth.

“We are outpacing our 2020 growth projections due to strong product demand and ongoing digital investments that empower our sales leaders and affiliates to build a socially enabled business. We are also benefitting from the current environment where more individuals are working from home and shopping online. Currently, approximately 90 percent of Nu Skin revenue is coming from digital transactions.”

- more -
Nu Skin Enterprises Reports Third-quarter 2020 Results, Raises Guidance
Page 2
Q3 2020 Year-Over-Year Operating Results

Revenue:
    
$703.3 million compared to $589.9 million
•          Less than (1%) fx impact
Gross Margin:
    
73.9% compared to 76.2%
•          Nu Skin business was 76.3% compared to 78.6%
•          Impacted by increased freight charges and geographic mix
Selling Expenses:
    
39.9% compared to 39.3%
•          Nu Skin business was 42.4% compared to 41.5%
G&A Expenses:
    
23.5% compared to 25.1%
Operating Margin:
    
10.6% compared to 11.8%
•          Impacted by lower gross margin
Other Income / (Expense):
    
$0.5 million compared to ($5.0) million
Income Tax Rate:
    
24.7% compared to 32.1%
•          Benefited by geographic mix
EPS:
    
$1.08 compared to $0.79

Stockholder Value

Dividend Payments:
    
$19.2 million
Stock Repurchases:
    
$20.0 million
•          $342.8 million remaining in authorization

Q4 and Full-Year 2020 Outlook

Q4 2020 Revenue:
    
$720 to $750 million; +23 to 29%
•          Approximately +1% fx impact
Q4 2020 EPS:
    
$1.10 to $1.20; +53 to 67%
2020 Revenue:
    
$2.55 to $2.58 billion; +6 to 7%
•          Approximately (1%) fx impact
2020 EPS:
    
$3.35 to $3.45; +8 to 11%

“The growth in our core Nu Skin business is generating a great deal of energy ahead of our fourth-quarter ageLOC Boost and Nutricentials product introductions, and we continue to see increasing demand in our manufacturing segment. This gives us confidence that we will have a strong fourth quarter with momentum heading into 2021 when we fully launch these products and continue to extend our socially enabled business throughout our markets,” Wood concluded.

- more -
Nu Skin Enterprises Reports Third-quarter 2020 Results, Raises Guidance
Page 3
Mark Lawrence, chief financial officer, added, “Given our third-quarter results above previous guidance and momentum in the business, we are raising our guidance for the remainder of the year. As we look ahead to the fourth quarter, we anticipate revenue of $720 to $750 million, which includes an approximate 1 percent favorable foreign currency impact, and earnings per share of $1.10 to $1.20. We are raising our 2020 revenue guidance to $2.55 to $2.58 billion, which reflects a negative foreign currency impact of approximately 1 percent, and we anticipate annual earnings per share of $3.35 to $3.45.”
 
Conference Call
The Nu Skin Enterprises management team will host a conference call with the investment community today at 5 p.m. (ET). Those wishing to access the webcast, as well as the financial information presented during the call, can visit the Investor Relations page on the company’s website at ir.nuskin.com. A replay of the webcast will be available at the same URL through Nov. 18, 2020.
 
About Nu Skin Enterprises, Inc.
Founded more than 35 years ago, Nu Skin Enterprises, Inc. (NSE) empowers innovative companies to change the world with sustainable solutions, opportunities, technologies and life-improving values. The company currently focuses its efforts around innovative consumer products, product manufacturing and controlled environment agriculture technology. The NSE family of companies includes Nu Skin, which develops and distributes a comprehensive line of premium-quality beauty and wellness solutions through a global network of sales leaders in Asia, the Americas, Europe, Africa and the Pacific; and Rhyz, our strategic investment arm that includes a collection of sustainable manufacturing and technology innovation companies. Nu Skin Enterprises is traded on the New York Stock Exchange under the symbol “NUS.” More information is available at nuskinenterprises.com.
 
Important Information Regarding Forward-Looking Statements: This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that represent the company’s current expectations and beliefs. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws and include, but are not limited to, statements of management’s expectations regarding the company’s performance, growth, product launches, customers and sales leaders, strategies and initiatives; statements of management’s expectations regarding the future status of the COVID-19 pandemic globally and across the company’s markets, and government and public behavior in response to such status; projections regarding revenue, earnings per share, foreign currency fluctuations and other financial items; statements of belief; and statements of assumptions underlying any of the foregoing. In some cases, you can identify these statements by forward-looking words such as “believe,” “expect,” “continue,” “anticipate,” “project,” “outlook,” “guidance,” “plan,” “continue,” “will,” “would,” “could,” “may,” “might,” the negative of these words and other similar words.

- more -
Nu Skin Enterprises Reports Third-quarter 2020 Results, Raises Guidance
Page 4
The forward-looking statements and related assumptions involve risks and uncertainties that could cause actual results and outcomes to differ materially from any forward-looking statements or views expressed herein. These risks and uncertainties include, but are not limited to, the following:

 •
risk that epidemics, including the ongoing COVID-19 outbreak, and other crises could negatively impact our business;

•
adverse publicity related to the company’s business, products, industry or any legal actions or complaints by the company’s sales force or others;

•
risk that direct selling laws and regulations in any of the company’s markets, including the United States and Mainland China, may be modified, interpreted or enforced in a manner that results in negative changes to the company’s business model or negatively impacts its revenue, sales force or business, including through the interruption of sales activities, loss of licenses, imposition of fines, or any other adverse actions or events;

•
any failure of current or planned initiatives or products to generate interest among the company’s sales force and customers and generate sponsoring and selling activities on a sustained basis;

•
political, legal, tax and regulatory uncertainties associated with operating in international markets, including Mainland China;

•
uncertainty regarding meeting restrictions and other government scrutiny in Mainland China, as well as negative media and consumer sentiment in Mainland China on our business operations and results;

•
risk of foreign-currency fluctuations and the currency translation impact on the company’s business associated with these fluctuations;

•
uncertainties regarding the future financial performance of the businesses the company has acquired;

•
risks related to accurately predicting, delivering or maintaining sufficient quantities of products to support planned initiatives or launch strategies, and increased risk of inventory write-offs if the company over-forecasts demand for a product or changes its planned initiatives or launch strategies;

•
regulatory risks associated with the company’s products, which could require the company to modify its claims or inhibit its ability to import or continue selling a product in a market if the product is determined to be a medical device or if the company is unable to register the product in a timely manner under applicable regulatory requirements;

•
unpredictable economic conditions and events globally, including trade policies and tariffs;

•
uncertainties related to interpretation of, and forthcoming regulations under, the recently enacted U.S. tax reform legislation; the company’s future tax-planning initiatives; any prospective or retrospective increases in duties on the company’s products imported into the company’s markets outside of the United States; and any adverse results of tax audits or unfavorable changes to tax laws in the company’s various markets; and

•
continued competitive pressures in the company’s markets.
 
The company’s financial performance and the forward-looking statements contained herein are further qualified by a detailed discussion of associated risks set forth in the documents filed by the company with the Securities and Exchange Commission. The forward-looking statements set forth the company’s beliefs as of the date that such information was first provided, and the company assumes no duty to update the forward-looking statements contained in this release to reflect any change except as required by law.

Non-GAAP Financial Measures: Constant-currency revenue change is a non-GAAP financial measure that removes the impact of fluctuations in foreign-currency exchange rates, thereby facilitating period-to-period comparisons of the company’s performance. It is calculated by translating the current period’s revenue at the same average exchange rates in effect during the applicable prior-year period and then comparing that amount to the prior-year period’s revenue. The company believes that constant-currency revenue change is useful to investors, lenders and analysts because such information enables them to gauge the impact of foreign-currency fluctuations on the company’s revenue from period to period.

- more -
Nu Skin Enterprises Reports Third-quarter 2020 Results, Raises Guidance
Page 5
The following table sets forth revenue for the three-month periods ended September 30, 2020 and 2019 for each of our reportable segments (U.S. dollars in thousands):

   
Three Months Ended
September 30,
          
Constant-
Currency
  
   
2020
    
2019
    
Change
    
Change
  
Nu Skin
                        
Mainland China
  
$
169,068
    
$
173,974
      
(3
)%
    
(4
)%
Americas/Pacific
    
151,465
      
83,635
      
81
%
    
90
%
South Korea
    
83,460
      
79,435
      
5
%
    
5
%
Southeast Asia
    
84,102
      
78,963
      
7
%
    
8
%
Japan
    
70,958
      
67,197
      
6
%
    
4
%
EMEA
    
61,411
      
35,742
      
72
%
    
67
%
Hong Kong/Taiwan
    
42,265
      
40,449
      
4
%
    
—
  
Other
    
(314
)
    
(62
)
    
(406
)%
    
(403
)%
Total Nu Skin
    
662,415
      
559,333
      
18
%
    
19
%
Manufacturing
    
40,910
      
30,601
      
34
%
    
34
%
Grow Tech
    
22
      
—
      
100
%
    
100
%
Total
  
$
703,347
    
$
589,934
      
19
%
    
19
%

The following table sets forth revenue for the nine-month periods ended September 30, 2020 and 2019 for each of our reportable segments (U.S. dollars in thousands):

   
Nine Months Ended
September 30,
          
Constant-
Currency
  
   
2020
    
2019
    
Change
    
Change
  
Nu Skin
                        
Mainland China
  
$
453,096
    
$
567,795
      
(20
)%
    
(19
)%
Americas/Pacific
    
353,957
      
262,932
      
35
%
    
43
%
South Korea
    
236,094
      
248,020
      
(5
)%
    
(2
)%
Southeast Asia
    
220,517
      
226,853
      
(3
)%
    
(1
)%
Japan
    
200,549
      
194,557
      
3
%
    
2
%
EMEA
    
147,590
      
120,960
      
22
%
    
23
%
Hong Kong/Taiwan
    
115,253
      
124,719
      
(8
)%
    
(10
)%
Other
    
374
      
(239
)
    
256
%
    
256
%
Total Nu Skin
    
1,727,430
      
1,745,597
      
(1
)%
    
1
%
Manufacturing
    
105,975
      
91,430
      
16
%
    
16
%
Grow Tech
    
336
      
30
      
1,020
%
    
1,020
%
Total
  
$
1,833,741
    
$
1,837,057
      
—
      
2
%

The Company’s Customers and Sales Leaders statistics by segment as of September 30, 2020 and 2019 are presented in the following table:

   
As of
September 30, 2020
    
As of
September 30, 2019
    
% Increase (Decrease)
  
   
Customers
    
Sales
Leaders
    
Customers
    
Sales
Leaders
    
Customers
    
Sales
Leaders
  
                                     
Mainland China
    
341,386
      
20,970
      
317,257
      
23,776
      
8
%
    
(12
)%
Americas/Pacific
    
438,889
      
14,400
      
229,013
      
7,760
      
92
%
    
86
%
South Korea
    
164,256
      
7,973
      
169,589
      
7,363
      
(3
)%
    
8
%
Southeast Asia
    
163,536
      
8,357
      
145,845
      
7,936
      
12
%
    
5
%
Japan
    
126,896
      
6,523
      
128,373
      
5,964
      
(1
)%
    
9
%
EMEA
    
235,202
      
6,226
      
147,758
      
4,060
      
59
%
    
53
%
Hong Kong/Taiwan
    
69,346
      
4,067
      
68,862
      
4,231
      
1
%
    
(4
)%
Total
    
1,539,511
      
68,516
      
1,206,697
      
61,090
      
28
%
    
12
%

- more -
Nu Skin Enterprises Reports Third-quarter 2020 Results, Raises Guidance
Page 6
“Customers” are persons who purchased products directly from the company during the previous three months. Our Customer numbers do not include consumers who purchase products directly from members of our sales force.

“Sales Leaders” are independent distributors, and sales employees and independent marketers in China, who achieve certain qualification requirements.

NU SKIN ENTERPRISES, INC.
Consolidated Statements of Income (Unaudited)
(U.S. dollars in thousands, except per share amounts)

   
Three Months Ended
September 30,
    
Nine Months Ended
September 30,
  
   
2020
    
2019
    
2020
    
2019
  
                         
Revenue
  
$
703,347
    
$
589,934
    
$
1,833,741
    
$
1,837,057
  
Cost of sales
    
183,374
      
140,162
      
463,277
      
440,854
  
Gross profit
    
519,973
      
449,772
      
1,370,464
      
1,396,203
  
                                 
Operating expenses:
                                
Selling expenses
    
280,695
      
231,937
      
735,365
      
727,473
  
General and administrative expenses
    
165,050
      
147,943
      
466,232
      
455,983
  
Total operating expenses
    
445,745
      
379,880
      
1,201,597
      
1,183,456
  
                                 
Operating income
    
74,228
      
69,892
      
168,867
      
212,747
  
Other income (expense), net
    
525
      
(4,979
)
    
(4,068
)
    
(11,153
)
                                 
Income before provision for income taxes
    
74,753
      
64,913
      
164,799
      
201,594
  
Provision for income taxes
    
18,446
      
20,823
      
46,911
      
68,153
  
                                 
Net income
  
$
56,307
    
$
44,090
    
$
117,888
    
$
133,441
  
                                 
Net income per share:
                                
Basic
  
$
1.10
    
$
0.79
    
$
2.24
    
$
2.40
  
Diluted
  
$
1.08
    
$
0.79
    
$
2.23
    
$
2.39
  
                                 
Weighted-average common shares outstanding (000s):
                                
Basic
    
51,308
      
55,548
      
52,741
      
55,507
  
Diluted
    
52,243
      
55,788
      
52,906
      
55,950
  

- more -
Nu Skin Enterprises Reports Third-quarter 2020 Results, Raises Guidance
Page 7
NU SKIN ENTERPRISES, INC.
Consolidated Balance Sheets (Unaudited)
(U.S. dollars in thousands)

   
September 30,
2020
    
December 31,
2019
  
ASSETS
            
Current assets:
            
Cash and cash equivalents
  
$
366,710
    
$
335,630
  
Current investments
    
11,301
      
8,413
  
Accounts receivable, net
    
60,016
      
50,378
  
Inventories, net
    
270,319
      
275,891
  
Prepaid expenses and other
    
63,916
      
69,854
  
Total current assets
    
772,262
      
740,166
  
                 
Property and equipment, net
    
456,083
      
453,604
  
Right-of-use assets
    
165,749
      
144,326
  
Goodwill
    
196,573
      
196,573
  
Other intangible assets, net
    
74,391
      
80,321
  
Other assets
    
151,653
      
154,016
  
Total assets
  
$
1,816,711
    
$
1,769,006
  
                 
LIABILITIES AND STOCKHOLDERS’ EQUITY
                
Current liabilities:
                
Accounts payable
  
$
55,298
    
$
38,979
  
Accrued expenses
    
381,052
      
290,281
  
Current portion of long-term debt
    
30,000
      
27,500
  
Total current liabilities
    
466,350
      
356,760
  
                 
                 
Operating lease liabilities
    
121,439
      
105,701
  
Long-term debt
    
312,664
      
334,461
  
Other liabilities
    
88,785
      
96,795
  
Total liabilities
    
989,238
      
893,717
  
                 
                 
Stockholders’ equity:
                
Class A common stock
    
91
      
91
  
Additional paid-in capital
    
570,491
      
557,544
  
Treasury stock, at cost
    
(1,446,374
)
    
(1,324,826
)
Accumulated other comprehensive loss
    
(83,108
)
    
(85,292
)
Retained earnings
    
1,786,373
      
1,727,772
  
Total stockholders’ equity
    
827,473
      
875,289
  
Total liabilities and stockholders’ equity
  
$
1,816,711
    
$
1,769,006
  

# # #
 
CONTACTS:
Media: media@nuskin.com, (801) 345-6397
Investors: investorrelations@nuskin.com, (801) 345-3577


 EX-101.SCH 3 nus-20201104.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 nus-20201104_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Amendment Flag City Area Code Entity Address, City or Town Entity Address, Country Document Period End Date Entity Incorporation, State or Country Code Local Phone Number Entity Address, Postal Zip Code Entity Address, State or Province Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Entity Registrant Name Entity Central Index Key Entity Tax Identification Number Document Fiscal Year Focus Document Fiscal Period Focus Document Type Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Entity File Number Entity Emerging Growth Company EX-101.PRE 5 nus-20201104_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 image00001.jpg begin 644 image00001.jpg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brhc10016590_8k_htm.xml IDEA: XBRL DOCUMENT 0001021561 2020-11-04 2020-11-04 false 0001021561 8-K 2020-11-04 NU SKIN ENTERPRISES, INC. DE 001-12421 87-0565309 75 West Center Street Provo UT 84601 801 345-1000 false false false false Class A Common Stock, $.001 par value NUS NYSE false XML 8 R1.htm IDEA: XBRL DOCUMENT v3.20.2
Document and Entity Information
Nov. 04, 2020
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Nov. 04, 2020
Entity Registrant Name NU SKIN ENTERPRISES, INC.
Entity Incorporation, State or Country Code DE
Entity File Number 001-12421
Entity Tax Identification Number 87-0565309
Entity Address, Address Line One 75 West Center Street
Entity Address, City or Town Provo
Entity Address, State or Province UT
Entity Address, Postal Zip Code 84601
City Area Code 801
Local Phone Number 345-1000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0001021561
Title of 12(b) Security Class A Common Stock, $.001 par value
Trading Symbol NUS
Security Exchange Name NYSE
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 1 95 1 false 0 0 false 0 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://nuskin.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports brhc10016590_8k.htm brhc10016590_ex99-1.htm nus-20201104.xsd nus-20201104_lab.xml nus-20201104_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "brhc10016590_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "brhc10016590_8k.htm" ] }, "labelLink": { "local": [ "nus-20201104_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "nus-20201104_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "nus-20201104.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd", "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "https://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 29, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "nus", "nsuri": "http://nuskin.com/20201104", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10016590_8k.htm", "contextRef": "c20201104to20201104", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000100 - Document - Document and Entity Information", "role": "http://nuskin.com/role/DocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10016590_8k.htm", "contextRef": "c20201104to20201104", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://nuskin.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://nuskin.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://nuskin.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://nuskin.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://nuskin.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://nuskin.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://nuskin.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://nuskin.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://nuskin.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://nuskin.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://nuskin.com/role/DocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://nuskin.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://nuskin.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://nuskin.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://nuskin.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://nuskin.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://nuskin.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://nuskin.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://nuskin.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://nuskin.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://nuskin.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://nuskin.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://nuskin.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://nuskin.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://nuskin.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://nuskin.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://nuskin.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://nuskin.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 15 0001140361-20-024544-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001140361-20-024544-xbrl.zip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